RIL
NKTR icon

Rothschild Investment LLC’s Nektar Therapeutics NKTR Stock Holding History

Rothschild Investment LLC’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47K Buy
+21
New +$1.54K ﹤0.01% 2890

Other funds holding NKTR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BCM
Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
ACL
APEIRON Capital Ltd Hong Kong $156M AUM 183.17% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Rothschild Investment LLC's NKTR Position: Q2 2026 in Review

Rothschild Investment LLC opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 21 shares worth $1.47K. The stake represents ﹤0.01% of the portfolio and ranks #2890 among its holdings.

63 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Rothschild Investment LLC held 21 shares of Nektar Therapeutics worth $1.47K as of Q2 2026.
  • Nektar Therapeutics was a new Rothschild Investment LLC position in Q2 2026.
  • Nektar Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2890 holding.
  • 63 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.